Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model

In the NCT03575611 oligometastatic ccRCC cohort, baseline and 3-month plasma KIM-1 and ctDNA MRD status were each independently associated with systemic therapy-free survival, and a Weibull model combining baseline KIM-1, baseline ctDNA, and four clinical variables (K-COMPASS) had a C-index of 0.76.

Eur UrolPubMed 41765697DOI 10.1016/j.eururo.2026.01.004